Cardioncology: From Molecular Mechanisms to Advanced Imaging and New Treatments

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 204

Special Issue Editors


E-Mail
Guest Editor
Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, Naples, Italy
Interests: heart failure; hypertension; cardiomyopathies; advanced cardiac multimodality imaging; cardioncology
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, Naples, Italy
Interests: heart failure; cardiomyopathies; pediatric cardiology; cardioncology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website1 Website2
Guest Editor
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Caserta, Italy
Interests: dyslipidemia; ischemic heart disease; atrial fibrillation; hypertension; acute coronary syndrome; heart failure; cardioncology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Advances in cancer therapies have significantly increased patient survival rates, but they carry the risk of cardiotoxicity, which requires effective monitoring and management.

Knowledge of the potential cardiovascular side effects of different classes of cancer therapies can improve understanding of their dose- and time-dependent impacts.

Shared inflammatory processes and immune system alterations characterize both cancer and cardiovascular disease. The immunological consequences of cancer treatments, especially with new biological therapies such as immunotherapy, underscore the need to explore the role of the immune system in determining cardiotoxicity at the molecular level.

Furthermore, despite the existence of several international guidelines and position papers regarding cardiovascular monitoring and management of patients receiving anticancer drugs, their limited empirical basis makes it difficult to determine a practical approach suitable for each clinical scenario.

This Special Issue “Cardioncology: From Molecular Mechanisms to Advanced Imaging and New Treatments” invites you to submit review articles, clinical cases or original papers with the aim to:

  1. Delve into the molecular mechanisms underlying the interplay between cardiovascular and cancer-related issues;
  2. Delve into the role of advanced imaging techniques in the diagnosis of early cardiotoxicity and monitoring of possible cardiovascular side effects of various classes of chemotherapeutics and radiotherapy;
  3. Deepen our understanding of the role of serum cardiac biomarkers in the diagnosis of early cardiotoxicity and monitoring of possible cardiovascular side effects of various classes of chemotherapeutics and radiotherapy;
  4. Delve into arrhythmic complications: diagnosis, monitoring and treatment;
  5. Describe the latest advances in treatments of cardiotoxicity.

Dr. Carla Contaldi
Dr. Giuseppe Pacileo
Prof. Dr. Paolo Calabrò
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiotoxicity
  • echocardiography
  • cardiac magnetic resonance
  • cardiac computed tomography
  • serum cardiac biomarkers
  • cancer therapy
  • arrhythmias
  • cardiotoxicity treatment

Published Papers

This special issue is now open for submission.
Back to TopTop